ATE141056T1 - Antitumorzusammensetzung die polypeptide mit der aktivität des humanen interleukin-2 enthält - Google Patents

Antitumorzusammensetzung die polypeptide mit der aktivität des humanen interleukin-2 enthält

Info

Publication number
ATE141056T1
ATE141056T1 AT91901812T AT91901812T ATE141056T1 AT E141056 T1 ATE141056 T1 AT E141056T1 AT 91901812 T AT91901812 T AT 91901812T AT 91901812 T AT91901812 T AT 91901812T AT E141056 T1 ATE141056 T1 AT E141056T1
Authority
AT
Austria
Prior art keywords
activity
human interleukin
pct
composition containing
containing polypeptides
Prior art date
Application number
AT91901812T
Other languages
English (en)
Inventor
Thomas Tursz
Maud Brandely
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Application granted granted Critical
Publication of ATE141056T1 publication Critical patent/ATE141056T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT91901812T 1990-10-30 1990-12-27 Antitumorzusammensetzung die polypeptide mit der aktivität des humanen interleukin-2 enthält ATE141056T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9013441A FR2668368B1 (fr) 1990-10-30 1990-10-30 Utilisation d'un polypeptide ayant l'activite de l'interleukine 2 humaine pour preparer une composition pharmaceutique destinee au traitement des tumeurs malignes epitheliales.

Publications (1)

Publication Number Publication Date
ATE141056T1 true ATE141056T1 (de) 1996-08-15

Family

ID=9401701

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91901812T ATE141056T1 (de) 1990-10-30 1990-12-27 Antitumorzusammensetzung die polypeptide mit der aktivität des humanen interleukin-2 enthält

Country Status (12)

Country Link
US (1) US5358709A (de)
EP (1) EP0507825B1 (de)
JP (1) JP2997050B2 (de)
KR (1) KR0168421B1 (de)
AT (1) ATE141056T1 (de)
AU (1) AU654944B2 (de)
CA (1) CA2071973A1 (de)
DE (1) DE69028020T2 (de)
DK (1) DK0507825T3 (de)
FR (1) FR2668368B1 (de)
WO (1) WO1992007577A1 (de)
ZA (1) ZA9010409B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
JP2003530839A (ja) 2000-04-12 2003-10-21 プリンシピア ファーマスーティカル コーポレイション アルブミン融合タンパク質
CA2349506C (en) 2001-06-14 2009-12-08 Duke University A method for selective expression of therapeutic genes by hyperthermia
EP2277910A1 (de) 2001-12-21 2011-01-26 Human Genome Sciences, Inc. Albumin Fusionsproteine
WO2005003296A2 (en) 2003-01-22 2005-01-13 Human Genome Sciences, Inc. Albumin fusion proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2635527B1 (fr) * 1988-07-28 1992-06-12 Roussel Uclaf Il2 humaine recombinante non glycosylee sous forme reduite, son procede d'obtention et son application comme medicament
FR2660863B1 (fr) * 1990-04-17 1994-01-21 Roussel Uclaf Utilisation d'un polypeptide ayant l'activite de l'interleukine 2 humaine pour preparer une composition pharmaceutique destinee au traitement de cancers primitifs de la plevre.

Also Published As

Publication number Publication date
JP2997050B2 (ja) 2000-01-11
EP0507825B1 (de) 1996-08-07
CA2071973A1 (fr) 1992-05-01
EP0507825A1 (de) 1992-10-14
KR0168421B1 (ko) 1999-01-15
FR2668368B1 (fr) 1995-03-10
DE69028020T2 (de) 1997-01-23
KR927003083A (ko) 1992-12-17
US5358709A (en) 1994-10-25
AU654944B2 (en) 1994-12-01
DK0507825T3 (da) 1996-10-07
DE69028020D1 (de) 1996-09-12
FR2668368A1 (fr) 1992-04-30
AU7052191A (en) 1992-05-26
ZA9010409B (en) 1992-05-27
JPH05502876A (ja) 1993-05-20
WO1992007577A1 (fr) 1992-05-14

Similar Documents

Publication Publication Date Title
KR950700333A (ko) 개량된 알파 인터페론 조성물 및 인간 말초혈 백혈구로부터의 제조 방법(improved alpha interferon composition and method for its production from human peripheral blood leukocytes)
ES8506087A1 (es) Procedimiento para preparar proteina de uroquinasa humana bioactiva
IT8467445A1 (it) Composizione e preparato per la somministrazione di medicamenti per via cutanea.
ES515032A0 (es) "proceso para la produccion microbiana de interferon fibroblasto humano".
DE69007744T2 (de) Verwendung von Interleukin 2 zur Behandlung von Leukämien.
HUT63769A (en) Process for producing pharmaceutical compositions comprising il-4 as active ingredient and suitable for treating thick tumours
HU9401369D0 (en) Human il-4 mutant proteins, thats containing pharmaceutical product and process for producing of proteins
ATE141056T1 (de) Antitumorzusammensetzung die polypeptide mit der aktivität des humanen interleukin-2 enthält
DK0452598T3 (da) Anvendelsen af et polypeptid med humant-inter-leukin-2-aktivitet til fremstilling af farmaceutiske præparater til behandling af primitiv pleuracancer
ATE240116T1 (de) Verwendung von human-beta-interferon zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von chronischer myeloidleukämie
DE3773295D1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
DE59206628D1 (en) Expression signalpeptid-freier staphylokinasen
DE3572441D1 (en) Use of interferon gamma (ifn-gamma) for the production of preparations for treating rheumatic diseases
EP0457921A4 (en) Novel platinum (ii) complex and drug for treating malignant tumor
FI874273A0 (fi) Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen
DK264787D0 (da) Anvendelse af humant alfa-interferon til fremstilling af et pharmaceutisk praeparat
ES2039276T3 (es) Uso de una combinacion de interferon gamma e interferon alfa para la preparacion de un medicamento para el tratamiento de ciertas leucemias.
ZA919682B (en) Use of a polypeptide having human interleukin 2 activity for the preparation of pharmaceutical compositions for the treatment of pneumothorax
SE8501203L (sv) Intestial deggdjurshormonprekursor och dess anvendning
DE69004051T2 (de) Verwendung eines Polypeptides mit Gammainterferon-Aktivität zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von primitivem Pleura-Krebs.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee